| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.07 | 0.2 |